Pinpointing who will and won’t get Alzheimer’s disease is tricky for doctors, but new research suggests it may soon get ...

Some 25 years ago, a young Parkinson's disease investigator, Robert Hauser, MD, stepped to the podium at an American Academy ...

Mayo Clinic researchers have developed a new artificial intelligence (AI) tool that helps clinicians identify brain activity ...

Ambroxol chaperones GCase; in a previous study of people with Parkinson's disease, the drug led to increased GCase levels. It ...

The FDA cleared an artificial intelligence (AI)-powered wristband (Felix NeuroAI) to treat upper-limb functional limitations ...

In the world of complicated brain surgeries, one name from India stands out — Dr Mohana Rao Patibandla. He is the CMD, CEO, ...

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) ranks among the 30 stocks expected to beat the market by 20 percentage points this ...

Epilepsy is among the most common neurological conditions, marked by unpredictable seizures, accidents and injuries, reduced ...

GABA, or gamma-aminobutyric acid, is an amino acid functioning as the principal inhibitory neurotransmitter that can act on ...

Sanofi's antibody riliprubart has received orphan drug designation (ODD) from Japan's Ministry of Health, Labour and Welfare ...

Epilepsy is among the most common neurological conditions, marked by unpredictable seizures, accidents and injuries, reduced ...

Robbins says that you shouldn’t be too concerned if you suffer from a bad night of sleep once in a while. (However, if you ...